MarketMindUS Markets Closed
AI-assisted · Not financial adviceNot adviceAI-assisted · Not financial advice.
Retail sentiment on SELLAS Life Sciences (SLS) is cautiously optimistic amid high short interest and potential squeeze. News of promise in AML treatments indicates growth potential.
SELLAS Life Sciences shows promise in AML treatments
Target: $3 avg (-36% upside)
5 Buy · 0 Hold · 0 Sell
Based on curated news sources (not retail comments)
Over the last 7 days: SELLAS Life Sciences shows strong cash reserves and optimism for trial results, but recent profit-taking has led to share price declines.